Rani Therapeutics Holdings(RANI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

RANI Rani Therapeutics Holdings

Market Closed 07-17 16:00:00 EDT

0.6973

+0.0274

+4.09%

盘后0.6800

-0.0173-2.48%

19:01 EDT

High0.7289	Low0.6510	Vol1.20M
Open0.6551	D1 Closing0.6699	Amplitude11.63%
Mkt Cap95.01M	Tradable Cap46.64M	Total Shares136.26M
T/O835.24K	T/O Rate1.79%	Tradable Shares66.89M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"RANI","market":"US","secType":"STK","nameCN":"Rani Therapeutics Holdings","latestPrice":0.6973,"timestamp":1784318400000,"preClose":0.6699,"halted":0,"volume":1195568,"hourTrading":{"tag":"盘后","latestPrice":0.68,"preClose":0.6973,"latestTime":"19:01 EDT","volume":6232,"amount":4285.2537,"timestamp":1784329266067,"change":-0.0173,"changeRate":-0.02481,"amplitude":0.043023},"delay":0,"changeRate":0.04090162710852363,"floatShares":66891000,"shares":136259511,"eps":-0.287185,"marketStatus":"Market Closed","change":0.0274,"latestTime":"07-17 16:00:00 EDT","open":0.6551,"high":0.7289,"low":0.651,"amount":835239.89714528,"amplitude":0.116286,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.287185,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1784534400000},"marketStatusCode":7,"adr":0,"listingDate":1627617600000,"exchange":"NASDAQ","adjPreClose":0.6699,"preHourTrading":{"tag":"盘前","latestPrice":0.651,"preClose":0.6699,"latestTime":"08:57 EDT","volume":1302,"amount":877.4010042,"timestamp":1784293078214,"change":-0.0189,"changeRate":-0.028213,"amplitude":0.042991},"postHourTrading":{"tag":"盘后","latestPrice":0.68,"preClose":0.6973,"latestTime":"19:01 EDT","volume":6232,"amount":4285.2537,"timestamp":1784329266067,"change":-0.0173,"changeRate":-0.02481,"amplitude":0.043023},"volumeRatio":1.453823453414767,"impliedVol":0.5953,"impliedVolPercentile":0.1195},"requestUrl":"/m/hq/s/RANI","defaultTab":"news","newsList":[{"id":"2651044687","title":"Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI), Urogen Pharma (URGN) and vTv Therapeutics (VTVT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651044687","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651044687?lang=en_us&edition=fundamental","pubTime":"2026-07-16 18:50","pubTimestamp":1784199034,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Rani Therapeutics Holdings (RANI), Urogen Pharma (UR...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-rani-therapeutics-holdings-rani-urogen-pharma-urgn-and-vtv-therapeutics-vtvt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-rani-therapeutics-holdings-rani-urogen-pharma-urgn-and-vtv-therapeutics-vtvt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","XLV","VTVT","BK4588","BK4137","LU0128526141.USD","RANI","BK4585","HCSG","LU0029874061.USD","BK4581","BK4007","BK4139","URGN","BK4539","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651463104","title":"Rani Therapeutics reports initial data from RT-114 study","url":"https://stock-news.laohu8.com/highlight/detail?id=2651463104","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651463104?lang=en_us&edition=fundamental","pubTime":"2026-07-15 20:40","pubTimestamp":1784119248,"startTime":"0","endTime":"0","summary":"Rani Therapeutics (RANI) reported initial data from the ongoing Phase 1 study of RT-114, an orally administered RaniPill Capsule delivering PG-102,...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/rani-therapeutics-reports-initial-data-from-rt-114-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/rani-therapeutics-reports-initial-data-from-rt-114-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0096364046.USD","LU0640476718.USD","LU2552382215.SGD","SG9999002224.SGD","LU1868836591.USD","BK4007","LU0320765646.SGD","BK4504","LU1066053197.SGD","LU2552382132.HKD","LU1868837300.USD","BK4533","UGE","LU1929549753.HKD","LU1585245621.USD","GB00BDT5M118.USD","FSTA","IE00BLSP4452.SGD","LU0323591593.USD","SG9999014542.SGD","SG9999002232.USD","PG","SG9999014575.USD","IE00BN8TJ469.HKD","LU1868836757.USD","LU1868836914.USD","LU0234572021.USD","BK4585","LU0868494617.USD","LU2242646821.SGD","LU2097829019.USD","LU2552382058.USD","LU2129689514.USD","SG9999015358.SGD","IE00BKDWB100.SGD","BK4018","LU0942090050.USD","IE00BWXC8680.SGD","IE000M9KFDE8.USD","XLP","LU1868837136.USD","LU1280957306.USD","IE00B1XK9C88.USD","RANI","IE00BLSP4239.USD","BK4567","LU0689626769.HKD","LU0061475181.USD","BK4539","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651468384","title":"Rani Therapeutics Says Oral Rt-114 Obesity Drug Candidate Tops Matched Injection Exposure in Phase 1a Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2651468384","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651468384?lang=en_us&edition=fundamental","pubTime":"2026-07-15 20:01","pubTimestamp":1784116918,"startTime":"0","endTime":"0","summary":"Rani Therapeutics says oral RT-114 obesity drug candidate tops matched injection exposure in Phase 1a dataRani Therapeutics reported positive initial Phase 1a data for RT-114, an oral RaniPill capsule","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nNDL2VvCn2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","RANI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651945005","title":"Rani Therapeutics Announces Positive Initial Phase 1a Data for Rt-114 for the Treatment of Obesity, with Oral Bioavailability Exceeding Matched Subcutaneous Dosing","url":"https://stock-news.laohu8.com/highlight/detail?id=2651945005","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651945005?lang=en_us&edition=fundamental","pubTime":"2026-07-15 20:00","pubTimestamp":1784116806,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nTUA8BSZV7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RANI","BK4539","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651889468","title":"Rani Therapeutics - Phase 1a Study Expanded with Additional Cohort to Define Pharmacokinetic Relationship","url":"https://stock-news.laohu8.com/highlight/detail?id=2651889468","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651889468?lang=en_us&edition=fundamental","pubTime":"2026-07-15 20:00","pubTimestamp":1784116806,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nTUA8BSZV7:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4539","RANI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651500194","title":"Rani Therapeutics - no Adverse Events Attributed to Ranipill Capsule; Treatment-related Events were Mild","url":"https://stock-news.laohu8.com/highlight/detail?id=2651500194","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651500194?lang=en_us&edition=fundamental","pubTime":"2026-07-15 20:00","pubTimestamp":1784116806,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nTUA8BSZV7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","RANI","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651450017","title":"Rani Therapeutics - Phase 1B Study Expected to Begin in 2026 with Data Anticipated in 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2651450017","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651450017?lang=en_us&edition=fundamental","pubTime":"2026-07-15 20:00","pubTimestamp":1784116806,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nTUA8BSZV7:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","RANI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650972521","title":"Rani Therapeutics Announces R&D Collaboration with Pegbio","url":"https://stock-news.laohu8.com/highlight/detail?id=2650972521","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650972521?lang=en_us&edition=fundamental","pubTime":"2026-07-10 04:58","pubTimestamp":1783630723,"startTime":"0","endTime":"0","summary":"BRIEF-Rani Therapeutics Announces R&D Collaboration With PegBioJuly 9 (Reuters)-Rani Therapeutics Holdings IncRANI.O:ANNOUNCES RESEARCH AND DEVELOPMENT COLLABORATION WITH PEGBIO TO EXPAND OBESITY PIPE","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260709:nTUABRCJ4G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RANI","BK4539","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650974118","title":"Rani Therapeutics announces research, development collaboration with PegBio","url":"https://stock-news.laohu8.com/highlight/detail?id=2650974118","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650974118?lang=en_us&edition=fundamental","pubTime":"2026-07-10 04:15","pubTimestamp":1783628121,"startTime":"0","endTime":"0","summary":"Rani Therapeutics (RANI) announced a research and development collaboration with PegBio to explore the delivery of multiple novel candidates from P...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/rani-therapeutics-announces-research-development-collaboration-with-pegbio-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/rani-therapeutics-announces-research-development-collaboration-with-pegbio-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","RANI","XT","BK4007","LENZ","BK4139","KNO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650974640","title":"Rani Therapeutics Partners with Pegbio to Develop Oral Obesity Drug Candidates","url":"https://stock-news.laohu8.com/highlight/detail?id=2650974640","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650974640?lang=en_us&edition=fundamental","pubTime":"2026-07-10 04:11","pubTimestamp":1783627893,"startTime":"0","endTime":"0","summary":"Rani Therapeutics partners with PegBio to develop oral obesity drug candidatesRani Therapeutics entered an R&D collaboration with PegBio to develop oral RaniPill formulations for multiple obesity and ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260709:nNDL2Yk8gq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK4539","02565","BK4007","RANI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650974374","title":"Rani Therapeutics Announces Research and Development Collaboration with Pegbio to Expand Obesity Pipeline Across Multiple Novel Candidates","url":"https://stock-news.laohu8.com/highlight/detail?id=2650974374","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650974374?lang=en_us&edition=fundamental","pubTime":"2026-07-10 04:05","pubTimestamp":1783627501,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260709:nTUABRCJ4G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","RANI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650974322","title":"Rani Therapeutics Holdings - Co and Pegbio to Develop Ranipill Formulations for Multiple Obesity Candidates","url":"https://stock-news.laohu8.com/highlight/detail?id=2650974322","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650974322?lang=en_us&edition=fundamental","pubTime":"2026-07-10 04:05","pubTimestamp":1783627501,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260709:nTUABRCJ4G:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4007","RANI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650791596","title":"Rani Therapeutics Files Form 3 for CFO Nicholas Maestas on Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2650791596","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650791596?lang=en_us&edition=fundamental","pubTime":"2026-07-09 04:05","pubTimestamp":1783541154,"startTime":"0","endTime":"0","summary":"Rani Therapeutics files Form 3 for CFO Nicholas Maestas on initial beneficial ownership statementRani Therapeutics named Nicholas Maestas as chief financial officer in an initial Form 3 filing dated J","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nNDL7B4ny:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RANI","BK4007","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647792643","title":"Rani Therapeutics Names Nicholas Maestas CFO, Replacing Svai Sanford","url":"https://stock-news.laohu8.com/highlight/detail?id=2647792643","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647792643?lang=en_us&edition=fundamental","pubTime":"2026-06-29 20:03","pubTimestamp":1782734616,"startTime":"0","endTime":"0","summary":"Rani Therapeutics names Nicholas Maestas CFO, replacing Svai SanfordRani Therapeutics appointed Nicholas Maestas as chief financial officer, effective immediately.Maestas previously served as CFO, hea","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nNDL3WzsD7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","SG9999014021.USD","TPST","IE00BN0W2T93.GBP","BK4007","RANI","LU2210150020.SGD","IE00BGHQF748.EUR","BK4139","SG9999014005.SGD","LU0314104364.USD","BK4585","SG9999014013.SGD","SG9999014039.USD","IE00BN0W2V16.EUR","BK4112","BK4588","LU2095319765.USD","BK4539","IE00BN0W2W23.USD","IE00B64PRP62.GBP","LU2210149790.SGD","NDAQ","IE00BKPKM429.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647379924","title":"Rani Therapeutics Holdings - Nicholas Maestas Succeeds Svai Sanford as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2647379924","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647379924?lang=en_us&edition=fundamental","pubTime":"2026-06-29 20:00","pubTimestamp":1782734404,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nTUAC3YCJR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RANI","BK4539","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639626712","title":"Rani Therapeutics stockholders elect directors at annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2639626712","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639626712?lang=en_us&edition=fundamental","pubTime":"2026-05-29 18:04","pubTimestamp":1780049053,"startTime":"0","endTime":"0","summary":"Rani Therapeutics held its annual shareholder meeting on May 28, 2026.Shareholders backed the selection of the company’s director nominees to serve until the 2027 annual meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rani Therapeutics Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 29, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDL128VVC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4539","RANI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638501987","title":"Rani Therapeutics Announces $20 Million Equity Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2638501987","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638501987?lang=en_us&edition=fundamental","pubTime":"2026-05-27 18:39","pubTimestamp":1779878388,"startTime":"0","endTime":"0","summary":"Rani Therapeutics Holdings ( ($RANI) ) has issued an update. On May 26, 2026, Rani Therapeutics Holdings, Inc. entered into a securities purchase a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/rani-therapeutics-announces-20-million-equity-financing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/rani-therapeutics-announces-20-million-equity-financing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4215","EQR","BK4007","BK4588","LENZ","BK4539","BK4139","RANI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638594514","title":"Rani Therapeutics prices USD 20 million registered direct stock offering at USD 1.07 per share","url":"https://stock-news.laohu8.com/highlight/detail?id=2638594514","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638594514?lang=en_us&edition=fundamental","pubTime":"2026-05-26 20:06","pubTimestamp":1779797193,"startTime":"0","endTime":"0","summary":"Rani Therapeutics priced a USD 20 million registered direct offering of Class A common stock priced at-the-market under Nasdaq rules.Deal includes 12,476,637 Class A shares at USD 1.07 each.Also includes pre-funded warrants for 6,214,953 Class A shares at USD 1.07 each, with a USD 0.0001 exercise price.Offering is expected to close on May 27, 2026, subject to customary conditions.H.C. Wainwright is lead placement agent; Chardan Capital Markets is placement agent.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rani Therapeutics Holdings Inc. published the original content used to generate this news brief on May 26, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nNDLbqgHC1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","RANI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638511402","title":"Rani Therapeutics Holdings, Inc. Announces Pricing of $20.0 Million Registered Direct Offering of Class a Common Stock Priced at-the-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2638511402","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638511402?lang=en_us&edition=fundamental","pubTime":"2026-05-26 20:00","pubTimestamp":1779796800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nTUA2JQV7W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4539","RANI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638514357","title":"Rani Therapeutics Holdings, Inc. Announces Pricing of $20.0 Million Registered Direct Offering of Class A Common Stock Priced At-The-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2638514357","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638514357?lang=en_us&edition=fundamental","pubTime":"2026-05-26 20:00","pubTimestamp":1779796800,"startTime":"0","endTime":"0","summary":"SAN JOSE, Calif., May  26, 2026  (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral deliv","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/26/3301000/0/en/Rani-Therapeutics-Holdings-Inc-Announces-Pricing-of-20-0-Million-Registered-Direct-Offering-of-Class-A-Common-Stock-Priced-At-The-Market-Under-Nasdaq-Rules.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","RANI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ranitherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0147},{"period":"1month","weight":-0.0887},{"period":"3month","weight":-0.2709},{"period":"6month","weight":-0.4983},{"period":"1year","weight":0.6726},{"period":"ytd","weight":-0.4835}],"compareEarnings":[{"period":"1week","weight":-0.0154},{"period":"1month","weight":0.0031},{"period":"3month","weight":0.0467},{"period":"6month","weight":0.0746},{"period":"1year","weight":0.1835},{"period":"ytd","weight":0.09}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics for patients, physicians, and healthcare systems in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies. Its product pipeline includes RT-102, a parathyroid hormone that is in Phase I clinical trial for the treatment of osteoporosis; RT-105, an anti-TNF-alpha antibody that is in preclinical studies to treat psoriatic arthritis; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; and RT-111, an ustekinumab biosimilar for the treatment of various inflammatory conditions. The has a collaboration agreement with ProGen Co., Ltd. for the o-development and commercialization of RT-114 to treat obesity. Rani Therapeutics Holdings, Inc. was founded in 2012 and is headquartered in San Jose, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.030292},{"month":2,"riseRate":0.8,"avgChangeRate":0.053306},{"month":3,"riseRate":0,"avgChangeRate":-0.236131},{"month":4,"riseRate":0.4,"avgChangeRate":0.191507},{"month":5,"riseRate":0.2,"avgChangeRate":-0.152617},{"month":6,"riseRate":0.2,"avgChangeRate":-0.134882},{"month":7,"riseRate":0.6,"avgChangeRate":-0.033508},{"month":8,"riseRate":0.4,"avgChangeRate":0.087585},{"month":9,"riseRate":0.2,"avgChangeRate":-0.146008},{"month":10,"riseRate":0.6,"avgChangeRate":0.658105},{"month":11,"riseRate":0.6,"avgChangeRate":0.053129},{"month":12,"riseRate":0.2,"avgChangeRate":-0.107417}],"exchange":"NASDAQ","name":"Rani Therapeutics Holdings","nameEN":"Rani Therapeutics Holdings"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Rani Therapeutics Holdings(RANI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Rani Therapeutics Holdings(RANI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Rani Therapeutics Holdings,RANI,Rani Therapeutics Holdings股票,Rani Therapeutics Holdings股票老虎,Rani Therapeutics Holdings股票老虎国际,Rani Therapeutics Holdings行情,Rani Therapeutics Holdings股票行情,Rani Therapeutics Holdings股价,Rani Therapeutics Holdings股市,Rani Therapeutics Holdings股票价格,Rani Therapeutics Holdings股票交易,Rani Therapeutics Holdings股票购买,Rani Therapeutics Holdings股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Rani Therapeutics Holdings(RANI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Rani Therapeutics Holdings(RANI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}